Physician profile
James Kasten
NPI 1649264128
$2,101.83
in general payments reported to CMS, 2019-2025
25 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $202 · 2021: $295 · 2022: $380 · 2023: $584 · 2024: $107 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814 · Education: $61.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.33 |
| Education | $61.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $487.55 | 2019-2025 | |
| Amgen INC. | $301.98 | 2019-2024 | Prolia, Evenity |
| Mayne Pharma Commercial LLC | $202.84 | 2021-2025 | |
| Organon LLC | $137.38 | 2021-2024 | Nexplanon |
| Astellas Pharma US INC | $130.85 | 2019-2023 | Veozah |
| Hologic Sales and Service, LLC | $114.06 | 2020 | |
| Therapeuticsmd, INC. | $114.01 | 2019-2022 | |
| Seagen INC. | $81.71 | 2023 | Tukysa |
| Myriad Women'S Health, INC. | $59.84 | 2023 | Myrisk |
| Channel Medsystems, INC. | $58.98 | 2023 | |
| Avion Pharmaceuticals | $55.94 | 2021-2022 | |
| Applied Medical Resources Corporation | $47.86 | 2022 | |
| Allergan, INC. | $42.23 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $40.36 | 2021-2025 | Exparel |
| Pfizer INC. | $37.06 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $33.48 | 2019 | |
| Exeltis, USA INC. | $32.43 | 2021 | |
| Novo Nordisk INC | $30.63 | 2025 | Wegovy |
| Mylan Pharmaceuticals INC. | $16.11 | 2021 | |
| Becton, Dickinson and Company | $15.45 | 2019 | |
| Daiichi Sankyo INC. | $13.88 | 2021 | |
| Lupin INC. | $12.67 | 2019 | |
| Myovant Sciences INC. | $12.40 | 2021 | |
| Coopersurgical, INC. | $11.08 | 2019 | |
| Merck Sharp & Dohme LLC | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kasten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.